Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer
- PMID: 12829565
- PMCID: PMC1126325
- DOI: 10.1136/bmj.326.7404.1456
Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer
Comment on
-
Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.BMJ. 2002 Oct 5;325(7367):766-70. doi: 10.1136/bmj.325.7367.766. BMJ. 2002. PMID: 12364308 Free PMC article. Review.
-
Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway?BMJ. 2003 May 3;326(7396):980-1. doi: 10.1136/bmj.326.7396.980. BMJ. 2003. PMID: 12727776 Free PMC article. Review. No abstract available.
References
-
- Hamdy FC, Donovan JL, Lane JA, Neal DE. Randomisation to clinical trials offers a solution to the dilemma of treatment choice in prostate cancer. bmj.com 2003. bmj.com/cgi/eletters/326/7396/980#33371 (accessed 20 June 2003). - PMC - PubMed
-
- Hanna CL, Mason MD, Donovan JL, Barber JP. Clinical oncologists favour radical radiotherapy for localised prostate cancer: a questionnaire survey study. Br J Urol Int 2002;90: 558-60. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical